Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00227110
What this trial is testing

Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
The University of Texas Health Science Center at San Antonio 55
Testing effectiveness (Phase 2)Study completedNCT01766713
What this trial is testing

Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
University of California, San Diego 50
Large-scale testing (Phase 3)Ended earlyNCT03028740
What this trial is testing

AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Tobira Therapeutics, Inc. 1,778
Early research (Phase 1)Study completedNCT00862433
What this trial is testing

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Who this might be right for
DiabetesFatty LiverObesity+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Testing effectiveness (Phase 2)Study completedNCT03061721
What this trial is testing

Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Zydus Therapeutics Inc. 106
Early research (Phase 1)Study completedNCT05848440
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 48
Not applicableWithdrawnNCT03962608
What this trial is testing

Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis

Who this might be right for
Non-Alcoholic Steatohepatitis
Yaqrit Ltd
Early research (Phase 1)Study completedNCT05983328
What this trial is testing

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

Who this might be right for
Nonalcoholic Steatohepatitis
Sinew Pharma Inc. 14
Not applicableStudy completedNCT00823277
What this trial is testing

Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight

Who this might be right for
Childhood ObesityNAFLD (Non-alcoholic Fatty Liver Disease)Hypertension+2 more
Holbaek Sygehus 517
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Not applicableStudy completedNCT02642172
What this trial is testing

Prebiotics in Patients With Non-alcoholic Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseMetabolic Syndrome
Kaplan Medical Center 24
Not applicableActive Not RecruitingNCT04835831
What this trial is testing

Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease (NAFLD
Centre Hospitalier Universitaire de Nice 115
Not applicableStudy completedNCT07768657
What this trial is testing

Improvement in Hepatic Function Through Sumac (Rhus Coriaria L.) Supplement Along With a Calorie-restricted Diet for the Management of Grade-I Obese Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
Liver BiomarkersLipid ProfileGlucose+1 more
University of Lahore 102
Not applicableStudy completedNCT04527965
What this trial is testing

Liver Fat as a Dietary Target for Treating Cardiometabolic Disorders in Prediabetes and Type 2 Diabetes

Who this might be right for
NAFLDDiabetes Mellitus, Type 2PreDiabetes
Uppsala University 150
Testing effectiveness (Phase 2)Study completedNCT00492700
What this trial is testing

A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Association pour la Recherche sur les Maladies Hépatiques Virales 63
Not applicableUnknownNCT02248311
What this trial is testing

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Who this might be right for
Type2 Diabetes MellitusMicroangiopathyNon Alcoholic Fatty Liver Disease+4 more
Hospital Universitari Vall d'Hebron Research Institute 260
Not applicableStudy completedNCT05844137
What this trial is testing

Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes

Who this might be right for
NAFLDDiabetes Mellitus
Duke University 10
Early research (Phase 1)Study completedNCT04845646
What this trial is testing

DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.

Who this might be right for
HealthyNAFLD
Gannex Pharma Co., Ltd. 24
Not applicableStudy completedNCT03791203
What this trial is testing

Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Universiti Sains Malaysia 43
Early research (Phase 1)Study completedNCT06308861
What this trial is testing

Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males

Who this might be right for
Non-alcoholic Steatohepatitis
J2H Biotech 100
Next Page